Pulmonx Corp ($LUNG)
Filing Information
| Accession Number | 0002098678-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 5, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
185,483
Total Value
$14,990.69
P&L
+inf% (+$224,875.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Science &Techn. Officer | Common Stock | โ | Mar 2, 2026 | Sale | 756 | $1.43 | $1,081.08 | 180,463 | Direct | โ | View Details | |
Chief Science &Techn. Officer | Common Stock | โ | Mar 2, 2026 | Sale | 3,068 | $1.43 | $4,387.24 | 177,395 | Direct | โ | View Details | |
Chief Science &Techn. Officer | Common Stock | โ | Mar 2, 2026 | Sale | 2,461 | $1.43 | $3,519.23 | 174,934 | Direct | โ | View Details | |
Chief Science &Techn. Officer | Common Stock | โ | Mar 2, 2026 | Sale | 4,198 | $1.43 | $6,003.14 | 170,736 | Direct | โ | View Details | |
Chief Science &Techn. Officer | Common Stock | โ | Mar 2, 2026 | Grant/Award | 175,000 | $0.00 | $0.00 | 345,736 | Direct | โ | View Details |